We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
Cap. Flow
-$1.11B
Cap. Flow %
-0.95%
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$89.2M
2
FLUT icon
Flutter Entertainment
FLUT
+$43.9M
3
OKTA icon
Okta
OKTA
+$32.1M
4
CHWY icon
Chewy
CHWY
+$31.8M
5
COIN icon
Coinbase
COIN
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 31.83%
2 Financials 13.86%
3 Consumer Discretionary 10.91%
4 Healthcare 9.41%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERT icon
1651
Certara
CERT
$1.23B
$3.09M ﹤0.01%
263,901
+3,447
+1% +$40.8K
KWT icon
1652
iShares MSCI Kuwait ETF
KWT
$69M
$3.08M ﹤0.01%
81,280
+440
+0.5% +$16K
BUSE icon
1653
First Busey Corp
BUSE
$2.58B
$3.07M ﹤0.01%
134,193
+6,445
+5% +$140K
IVW icon
1654
iShares S&P 500 Growth ETF
IVW
$77.5B
$3.07M ﹤0.01%
27,880
CRI icon
1655
Carter's
CRI
$1.41B
$3.06M ﹤0.01%
101,573
+17,438
+21% +$591K
AUO
1656
DELISTED
AU Optronics Corp
AUO
$3.05M ﹤0.01%
619,585
-54,652
-8% -$269K
NEOG icon
1657
Neogen
NEOG
$2.52B
$3.05M ﹤0.01%
637,814
+29,314
+5% +$168K
VKTX icon
1658
Viking Therapeutics
VKTX
$3.85B
$3.04M ﹤0.01%
114,533
-14,662
-11% -$386K
AAT
1659
American Assets Trust
AAT
$1.4B
$3.02M ﹤0.01%
152,868
+7,955
+5% +$155K
BCRX icon
1660
BioCryst Pharmaceuticals
BCRX
$2.44B
$3.02M ﹤0.01%
336,939
+15,785
+5% +$147K
KNTK icon
1661
Kinetik
KNTK
$4.34B
$3M ﹤0.01%
68,063
+8,371
+14% +$367K
AGIO icon
1662
Agios Pharmaceuticals
AGIO
$1.97B
$2.99M ﹤0.01%
89,881
+3,039
+3% +$92.1K
KLG
1663
DELISTED
WK Kellogg Co
KLG
$2.98M ﹤0.01%
186,988
+2,543
+1% +$44.2K
DNLI icon
1664
Denali Therapeutics
DNLI
$3.91B
$2.97M ﹤0.01%
212,503
+22,247
+12% +$313K
PRLB icon
1665
Protolabs
PRLB
$2.17B
$2.97M ﹤0.01%
74,070
-945
-1% -$35.2K
TIGO icon
1666
Millicom
TIGO
$15.7B
$2.96M ﹤0.01%
+79,062
New +$2.71M
RIG icon
1667
Transocean
RIG
$6.46B
$2.95M ﹤0.01%
1,140,122
+63,378
+6% +$163K
BTSG icon
1668
BrightSpring Health Services
BTSG
$12.2B
$2.94M ﹤0.01%
124,658
+47,558
+62% +$992K
ASTE icon
1669
Astec Industries
ASTE
$995M
$2.94M ﹤0.01%
70,438
+1,881
+3% +$71.4K
CVI icon
1670
CVR Energy
CVI
$3.56B
$2.93M ﹤0.01%
109,187
-6,114
-5% -$135K
MSEX icon
1671
Middlesex Water
MSEX
$1.1B
$2.9M ﹤0.01%
53,520
+1,740
+3% +$103K
ASTH icon
1672
Astrana Health
ASTH
$2B
$2.9M ﹤0.01%
116,521
+1,714
+1% +$48.3K
BBAI icon
1673
BigBear.ai
BBAI
$1.57B
$2.9M ﹤0.01%
426,845
+294,833
+223% +$1.07M
SAN icon
1674
Banco Santander
SAN
$209B
$2.9M ﹤0.01%
348,817
-7,659
-2% -$57K
ADT icon
1675
ADT
ADT
$5.46B
$2.89M ﹤0.01%
341,003
+24,582
+8% +$201K

Similar funds

RhumbLine Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
  • RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
  • RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
  • RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
  • RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
  • RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.